Princeton University

Venture capital investors are doubling down, placing new bets on drug developers even as the public markets are taking money off the table in the biopharmaceutical sector. For instance, Texas Medical

Olema Pharmaceuticals, Inc. is not hurting for money after raising $139m in venture capital so far in 2020, but the company went public in the US on 18 November anyway to speed up clinical developmen

Biopharma innovation traditionally has been nurtured in big academic or industry laboratories. Ethan Perlstein would like to change that. After Perlstein earned his stripes in Stuart Schreiber Harva

Biopharma innovation traditionally has been nurtured in big academic or industry laboratories. Ethan Perlstein, PhD, would like to change that. After Perlstein earned his stripes in Stuart Schreiber,